PR NEWSWIRE - Contenuti promozionali

CTA
immediapress/pr-newswire comunicato stampa

Pierre Fabre Laboratories riceve il parere positivo del CHMP per BRAFTOVI® (encorafenib) in combinazione con cetuximab e FOLFOX (fluorouracile, leucovorin e oxaliplatino) per il trattamento di prima linea di pazienti adulti con carcinoma colorettale metastatico (mCRC) con mutazione BRAFV600E

CASTRES, Francia, 26 maggio 2026 /PRNewswire/ -- Pierre Fabre Laboratories ha annunciato oggi che il Comitato per i medicinali per uso umano (Committee for Medicinal Products for Human Use, CHMP) dell'Agenzia europea per i medicinali (European Medicines Agency, EMA) ha emesso un parere positivo racco...

immediapress/pr-newswire comunicato stampa

Quest Global Named a Leader and Rising Star Across Six Quadrants in the ISG Provider Lens® Aerospace & Defense Services & Solutions 2026 Study across Europe, US, and Global markets

LONDON, May 26, 2026 /PRNewswire/ -- Quest Global, the world's largest independent pure-play engineering services company, has been recognized as a leader across six quadrants in the ISG Provider Lens™ Aerospace & Defense Services and Solutions 2026 study. This year's results mark a significant expan...

immediapress/pr-newswire comunicato stampa

"The Era of Cuffless is Here"… Ring-Type Blood Pressure Monitor 'CART BP pro' Becomes World's First to Be Integrated into Official Hypertension Guidelines

SEOUL, South Korea, May 26, 2026 /PRNewswire/ -- Sky Labs (CEO Jack ByungHwan Lee) announced on the 26th that its ring-type cuffless blood pressure monitor, 'CART BP pro,' has been officially integrated into the '2026 Korean Society of Hypertension Guidelines for the Management of Hypertension (6th E...



SEGUICI SUI SOCIAL

threads whatsapp linkedin twitter youtube facebook instagram

ora in
Prima pagina
articoli
in Evidenza